0 Kommentare
0 Anteile
1KB Ansichten
0 Vorschau
Search
Entdecken Sie neue Leute, neue Verbindungen zu schaffen und neue Freundschaften
-
Please log in to like, share and comment!
-
Hepatocellular Carcinoma Drugs Market Advances Amid Rising Focus on Targeted Cancer Therapies" According to the latest report published by Data Bridge Market Research, the Hepatocellular Carcinoma Drugs Market CAGR Value The global hepatocellular carcinoma drugs market was valued at USD 1.21 billion in 2024 and is expected to reach USD 2.27 billion by 2032 During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of...0 Kommentare 0 Anteile 480 Ansichten 0 Vorschau
-
Hepatocellular Carcinoma Drugs Market Advances With Increasing Focus on Targeted Cancer Therapies" According to the latest report published by Data Bridge Market Research, the Hepatocellular Carcinoma Drugs Market CAGR Value The global hepatocellular carcinoma drugs market was valued at USD 1.21 billion in 2024 and is expected to reach USD 2.27 billion by 2032 During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of...0 Kommentare 0 Anteile 327 Ansichten 0 Vorschau
-
Oral HER Pathway Targeted Drugs Market: Targeted Therapies Expand Innovation in Cancer Treatment" According to the latest report published by Data Bridge Market Research, the Oral HER Pathway Targeted Drugs Market CAGR Value An influential Oral HER Pathway Targeted Drugs Market report contains a specific study of the Oral HER Pathway Targeted Drugs Market industry which defines what the market definition, classifications, applications, engagements, and global industry...0 Kommentare 0 Anteile 184 Ansichten 0 Vorschau
-
Sarcoma Drugs Market Advances with Breakthroughs in Targeted Cancer Therapies" According to the latest report published by Data Bridge Market Research, the Sarcoma Drugs Market CAGR Value Data Bridge Market Research analyses that the sarcoma drugs market which was USD 1222.20 million in 2022, is expected to reach USD 2435.31 million by 2030, at a CAGR of 9.00% during the forecast period 2023 to 2030 This client-centric, leading edge and truthful Sarcoma...0 Kommentare 0 Anteile 564 Ansichten 0 Vorschau
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Kommentare 0 Anteile 2KB Ansichten 0 Vorschau
-
Driving Growth & Opportunities in the Global Oncology Small Molecule Drugs Market Through 2031The Oncology Small Molecule Drugs Market is witnessing transformative growth as pharmaceutical innovation accelerates to address the global cancer burden. With therapeutics that can penetrate cellular targets, modulate intracellular pathways, and be administered orally, small molecule oncology drugs are becoming essential components of cancer treatment regimens worldwide. The Oncology Small...0 Kommentare 0 Anteile 2KB Ansichten 0 Vorschau
-
Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology AdoptionAccording to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...0 Kommentare 0 Anteile 2KB Ansichten 0 Vorschau
-
Oncology Drugs Market to Reach USD 503.13 Billion by 2033, Growing at 11.6% CAGRMarket Overview The global oncology drugs market size was valued at USD 193.04 billion in 2024 and is projected to grow from USD 209.57 billion in 2025 to USD 503.13 billion by 2033, exhibiting a CAGR of 11.6% during the forecast period (2025-2033). The global Oncology Drugs market is witnessing swift transformation driven by new consumer behaviors, increased...0 Kommentare 0 Anteile 3KB Ansichten 0 Vorschau
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Kommentare 0 Anteile 2KB Ansichten 0 Vorschau
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek